(Reuters) -Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for ...

There's nothing swampier than handing over billions of taxpayer dollars to a pharmaceutical company that had already gotten ...

Enveric Biosciences secures a U.S. patent for non-hallucinogenic mescaline derivatives targeting addiction, ADHD and anxiety.

Nutriset, a French company, was founded by Michel Lescanne. He was one of two scientists who invented this product in 1996. A sticky peanut butter paste branded Plumpy'nut, it’s enriched with vitamins ...

These devices lacked essential medical certifications, representing a risk to public health and patient safety. This may result in adverse effects, allergic reactions and rejection of the treated ...

The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high- ...

A significant number of Americans experience chronic inflammatory skin conditions with no pinpointed cause and often no ...

NEW YORK CITY, NY / ACCESS Newswire / February 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...

Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...

In recent years, the rapid advancement of artificial intelligence (AI) and machine learning (ML) technologies has sparked a ...

Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete ...